Procured Health is now Lumere! Read More
Skip to Content

Lumere Appoints Scott A. Falk, MD, to Advisory Council

Physician to support company’s solutions and services with field-based insights CHICAGO, IL (February 20, 2018) — Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the appointment of Scott A. Falk, MD, to the firm’s Physician… read more

Lumere Names John Cherf, MD, MPH, MBA, as Its First-Ever Chief Medical Officer

Physician leader to support company’s clinical approach to reducing variation and costs CHICAGO, IL (February 6, 2018) — Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the appointment of John Cherf, MD, MPH, MBA, as… read more

Procured Health Expands Focus, Becomes Lumere

New Name and Positioning Reflects Broader Focus Within the Value-Based Care Environment CHICAGO, IL (January 24, 2018) – To better reflect its expanded focus, Procured Health, the leading provider of data-driven analytics, evidence and expert guidance to help health systems cut costs and reduce unwarranted clinical variation, has changed its… read more

Procured Health Launches Evidence-Based Pharmacy Solutions to Tackle Escalating Drug Spend and Inappropriate Utilization

CHICAGO, IL (October 16, 2017) — Procured Health, the foremost provider of actionable information to cut device costs and improve care along the patient pathway, today announced the launch of its web-based Pharmacy solutions. These solutions link a health system’s drug spend and utilization data to clinical evidence, providing healthcare… read more

Procured Health Hosts Annual Leadership Roundtable to Explore the Frontier of Healthcare Change

Chicago (September 07, 2017) — Procured Health, a leader in providing health systems with solutions that improve patient outcomesand operational efficiency, recently held “Seeking the Frontier,” the firm’s first annual Leadership Roundtable. During the event, administrative and clinical executives shared perspectives, insights and strategies to address the industry’s biggest challenges. “Healthcare… read more

Procured Health to Discuss Using Clinical Evidence to Reduce Costs, Improve Patient Care at AHRMM17

CHICAGO, IL (July 25, 2017) –  John Cherf, MD, MPH, MBA, chief of orthopedics at Advocate Illinois Masonic Medical Center, and Julie Schulz, MD, MPH, Procured Health vice president, will present “Leveraging Evidence-Based Medicine to Reduce Clinical Costs and Improve Outcomes” on Wednesday, July 26, at the AHRMM17 Conference in… read more

Guthrie Adopts Procured Health’s Full Solution Suite to Reduce Clinical Supply Spend Across the System

CHICAGO, IL (July 12, 2017) – Guthrie, an integrated health system with subspecialty and primary care sites in 22 communities throughout Pennsylvania and New York, announced that it would be adopting Procured Health’s full solution suite to reduce clinical supply spend as part of its ongoing initiatives to optimize performance across the… read more

Procured Health Appoints Michael Blaszyk as Board Member and Egon Doppenberg, MD, as Physician Advisor

Chicago, IL (June  15, 2017) – Procured Health, a leader in providing health systems with solutions that improve patient outcomes and operational efficiency, announced two key appointments today. Michael Blaszyk will join the firm’s board of directors while Egon Doppenberg, MD, will serve on the company’s Physician Advisory Council. Blaszyk brings… read more

Procured Health Introduces Market Insights to Drive Evidence-Based Medical Product Spending and Utilization

Chicago, IL (May 18, 2017) – Procured Health, a leader in providing health systems with solutions that improve both patient outcomes and operational efficiency, announced the addition of Market Insights to its cloud-based Analytics application. With Market Insights, health systems can for the first time combine clinical evidence with market… read more

Biosimilars: Disruption or Disappointment?

In a recent blog post, Allison Wu asks whether biosimilars are a disruption or a disappointment? Branded as “Inflectra”, this form of infliximab is developed by Celltrion and will be co-marketed by Pfizer. Despite steadily rising interest in biosimilars over the past 5 years, Inflectra is only the second true biosimilar drug… read more

Categories